NASONEX NASAL SPRAY

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

MOMETASONE FUROATE 50 MCG/DOSE

Dostupno od:

MERCK SHARP & DOHME ISRAEL LTD

ATC koda:

D07AC13

Farmaceutski oblik:

SOLUTION

Administracija rute:

NASAL

Proizveden od:

SCHERING-PLOUGH LAB.NV BELGIUM

Terapijska grupa:

MOMETASONE

Terapijske indikacije:

In adults and children 3 years of age and older to treat the symptoms of seasonal or perennial rhinitis. In patients 12 years old and above who have a history of moderate to severe symptoms of seasonal allergic rhinitis prophylactic treatment with Nasonex Aqueous Nasal Spary is recommended 2- 4 weeks prior to the anticipated start of the pollen season.

Datum autorizacije:

2013-03-01